Multipurpose, Reusable, Female Contraceptive Device That Enhances the Effectiveness of Fertility Awareness Methods and Controls Stress Incontinence
Main Article Content
Introduction: There is a significant deficiency in women’s reproductive health needs:
- Lack of options of non-hormonal contraceptive
- Fertility awareness method is the safest and yet it is rarely
- Women suffer from Stress Incontinence
Objectives: To provide women with one device that can be used for 1) Contraception by stopping sperm from entering the cervix, 2) To enhance the effectiveness of Fertility Awareness Methods by accurately detecting ovulation day and 3) Control Stress Urinary Incontinence by supporting the bladder neck.
Materials and Methods: We selected the FDA approved FemCap contraceptive device to determine its utility to fulfill the three basic reproductive health needs for women.
- The FemCap is a safe and effective, time tested, barrier contraceptive
- The FemCap can collect a large amount of fertile cervical mucous, that is not mixed with vaginal
- The use of currently available pessaries have significant limitations such as displacement, erosion or even ulceration and urethral
The FemCap shows marked similarity to the ring pessary with support. The Rim of the FemCap is similar in shape and function to the ring of the pessary that supports the bladder neck. The outward flaring brim restores the anatomy of the urethra and the vagina. The bowl of the FemCap supports the cervix and prevents it from descending, which is like the supported pessary.
Results: 1) The FemCap is a well-established barrier contraceptive device. 2) It is also has proven in pilot studies to enhance the effectiveness of fertility awareness methods and 3) control stress incontinence.
Conclusion: It would be ideal and cost effective for women to acquire one multipurpose reusable device that can be used for contraception to enhance fertility awareness and to control stress incontinence.
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
2. Shihata A, Microbicides Delivery System. 5th European Congress on Tropical Medicine and International Health. Proceedings Amsterdam May 24-28, 2007;131-134.
3. Shihata A, Novel Delivery System for Microbicides. Presented in 2007 National HIV Prevention Conference. 2007 378.
4. Pudney J, Quayle AJ, Anderson DJ. Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol Reprod 2005; 73: 1253–63.
5. Janet G. Vail, MPH, MBA, Jessica A. Cohen, MHS, and Kimberly L. Kelly, MPA Improving Topical Microbicide Applicators for Use in Resource-Poor Settings | American Journal of Public Health, Am J Public Health. 2004 Jul;94(7):1089-92
6. Koeniger-Donohue R, The FemCap a Non-Hormonal Contraceptive, Women’s Health Care NPWH.2006 Vol. 5, No 4 pp 79-91.
7. Carcio H, Clarke Secor M. Koeniger-Donohue R., Advanced Health Assessment of Women: Clinical Skills and Procedures Chapter 15 The FemCap. Springer Publishing Company 2010 Pages 271-278.
8. Shihata A, The FemCap™, a new contraceptive choice. Eur J Contracept and Reprod. Health Care, 1998; 3:160-166.
9. Shoupe D, Kjos S, The Handbook of Contraception, Barrier Contraceptives Chapter 10 Humana Press 2006 Pages 147-177.
10. Shihata A, New FDA approved woman-controlled, latex-free barrier contraceptive device “FemCap™”.
11. Billings JJ: Cervical mucus: The biological marker of fertility and infertility. International J Fertil 26:181, 1987
12. Pyper CMM: Fertility Awareness & Natural Family Planning. Eur J Contracept Reprod Health Care 2:131-146, 1997
13. Lamprecht V, Grummer-Strawn J: Development of new formulas to identify the fertile time of the menstrual cycle. Contraception 54:339-343, 1996
14. Shihata, Alfred, MD Brody Steven M.D Ph.D, Novel approach for women to identify the precise day of Ovulation to conceive or contracept. International Journal of Medical Science and Health Research. Vol4 No. 03 ;2020
15. G. WILLY DAVILA. Introl™ Bladder Neck Support Prosthesis: A Nonsurgical Urethropexy Journal of Endourology.Jun 1996.293-296 http://doi.org/10.1089/end.1996.10.293 Published in Volume: 10 Issue 3: March 30, 2009
16. Danny Lovatsis, Mount Sinai Hospital, Canada A Randomized Controlled Trial of the Uresta Continence Pessary (SURE) ClinicalTrials.gov Identifier: NCT01284244 Recruitment Status: Completed First Posted: January 26, 2011 Results First Posted : March 31, 2017 Last Update Posted: March 31, 2017